Al Jalila Foundation signs five strategic partnerships to advance healthcare through philanthropy
Under the patronage and in the presence of H.H. Sheikh Ahmed bin Saeed Al Maktoum, Chairman of Dubai Health Board of Directors, Al Jalila Foundation signed strategic agreements with five UAE-based charitable organisations during its annual donor recognition ceremony.
The partnerships aim to strengthen collaborative philanthropy in the UAE by delivering healthcare services to vulnerable communities and supporting medical education and scientific research.
The memoranda of understanding were signed by Dr. Amer Al Zarooni, CEO of Al Jalila Foundation, with: Dr. Raja Easa Al Gurg, Chairperson of Easa Saleh Al Gurg Charity Foundation; Abdullah Ali bin Zayed Al Falasi, CEO and Managing Director of Dar Al Ber Society; Ahmed Ibrahim Al Suwaidi, Executive Director of Dubai Charity Association; Dr. Ahmed Tahlek, General Director of Tarahum Charity Foundation; Abdeen Taher Al Awadhi, Director General of Beit Al Khair Society.
Dr. Al Zarooni stated, 'By joining forces with these mission-driven organisations, we ensure life-saving medical care reaches those most in need. These partnerships strengthen our healthcare ecosystem and reinforce Dubai's role as a global centre for philanthropic leadership.'
Abdullah Al Falasi highlighted that the partnership supports advanced medical care and reflects the UAE's socially responsible vision, while H.E. Ahmed Al Suwaidi said the collaboration aligns with the Dubai Charity Strategy to enhance humanitarian work and deliver lasting impact.
Dr. Ahmed Tahlek noted the agreement supports the development of community-based health initiatives, particularly for families facing critical illnesses. Abdeen Al Awadhi added that the partnership embodies the UAE's vision of prioritising public health and compassion.
The strategic agreements will fund key initiatives including A'awen, The Child Fund, and community programmes such as Wellness on Wheels, Ta'alouf, and Majlis Al Amal, pooling resources to improve lives across the UAE.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
The National
an hour ago
- The National
Prozac users in the UAE concerned as supplies of 'life-changing' drug dry up
Prozac users in the UAE are concerned about dwindling supplies after its global discontinuation last year, sparking conversations among patients and psychiatrists about available alternatives. Considered a cornerstone treatment for conditions like depression and anxiety, the medication is now fast disappearing from pharmacy shelves as stocks dry up. Internationally, the medication is widely available under other brand names however in the UAE Prozac has historically been the only option with this formula. Finding alternatives Prozac, which was manufactured by US drug company Lilly, is the brand name for fluoxetine, a type of medication known as a selective serotonin reuptake inhibitor (SSRI). It has been used for mental health conditions, including depression, anxiety, obsessive-compulsive disorder, premenstrual dysphoric disorder and bulimia nervosa since its launch in 1987. It is available on the market as a controlled medication and accessible to patients when prescribed by a psychiatrist. Now, patients may have to source their medication out of the country or try alternative pharmaceuticals, such as Zoloft (sertraline) or Cipralex (escitalopram), which have different base formulations and therefore different side effects depending on a person's biology. 'This decision is not related to the safety or efficacy of the medicine, but reflects the availability of broad alternative treatments and evolving business priorities,' a Lilly spokesperson told The National. 'We encourage patients currently on Prozac to speak to their healthcare provider about treatment options available to them. While no new supplies are being planned, limited stock may still be available locally through licensed distributors.' The National was able to locate some Prozac at pharmacies with leftover stocks at the time of writing, but many contacted were completely out. Global antidepressants usage While Prozac has been one of the most widely prescribed drugs of its kind for decades, the global antidepressant market is growing rapidly. It was valued at $18.7 billion in 2024 and is estimated to increase at a compound annual growth rate of 7.5 per cent from 2025 to 2034, when it is forecasted it will be worth $37.9 billion, according to Global Market Insights. This is being driven predominantly by mental health awareness and rising demand for effective treatments for various conditions. 'Impact was life-changing' One Dubai-based mother, who wished to remain anonymous, is concerned for her 11-year-old daughter, who has been taking Prozac for the past 18 months. "She is autistic and struggles with severe anxiety, OCD and specific phobias," she told The National. "We tried other SSRIs before, but none were effective. Prozac has been the only medication that made a noticeable difference, particularly for her OCD symptoms." The mother said since they'd heard Prozac is going out of stock in the UAE, they've been trying to source an alternative fluoxetine product from their home country. "Switching to another SSRI is not a viable option for her right now ... I trust that the authorities will take this matter seriously and work toward a solution, especially for children and families who rely on this medication for daily functioning and well-being." Dubai resident Victoria McKeown, who lived with 'crippling' anxiety for years until she was prescribed Prozac, is also concerned about the lack of availability in the future. 'While I wouldn't describe myself as clinically depressed, I tried several antidepressants over the years with little effect,' she told The National. 'That changed when I was prescribed a low dose of Prozac. The impact was life-changing – not just for me, but for those around me.' Ms McKeown's psychiatrist contacted her to say she will need to consider trying medications that had previously been ineffective. 'Right now, it seems my only option is to travel overseas, obtain a prescription there, and bring it back with me," she said. "It's incredibly disheartening that a medication which has helped so many people is no longer available here.' Experts are hopeful that an appropriate alternative will soon be available in the market, however. Dr Teizeem Dhanji, a child and adolescent psychiatrist and medical director at Dubai's Sage Clinics, said there is currently no confirmed guidance from authorities, but 'it is expected that substitute options will be introduced in due course'. The National has contacted the Emirates Drug Establishment for more details on when an alternative will be registered, but there was no confirmation at the time of writing. What patients can do now Dr Dhanji advised individuals taking fluoxetine to consult their treating psychiatrists to discuss the best course of action. 'Clinicians can help develop a personalised plan to safely and gradually taper the current medications and transition to an appropriate alternative if necessary," she said. "There are a number of safe and effective antidepressant options available in the UAE and so patients should consult their psychiatrist early.' It may also give some individuals the chance to reassess treatment needs and explore additional coping strategies or therapeutic options that may complement or replace medication, Dr Dhanji added. But the disruption could have a significant impact on the market, said Antony Bainbridge, head of clinical services and clinical lead at Resicare Alliance, a UK-based assessment and residential provider for children with mental health issues that plans to open a Dubai boarding facility soon. Mr Bainbridge said the lack of a substitute could require potentially disruptive changes in medication, particularly for patients who respond well to fluoxetine. 'Alternative SSRIs like sertraline, citalopram and paroxetine are available, but they have different side effect profiles and may not be as effective for every individual.' Patients switching from Prozac to another SSRI may experience withdrawal symptoms, relapse or other side effects during the transition, he added. 'The unavailability may lead to worsening of symptoms in some patients, increasing the burden on mental health services.' Mr Bainbridge also expressed concerns that patients could resort to unregulated or illegal sources to obtain the medication, 'posing significant safety risks'.
Gulf Business
5 hours ago
- Gulf Business
‘WHOOP 5.0 Is our biggest leap yet', says founder and CEO Will Ahmed
Images: Supplied With the launch of WHOOP 5.0 and the medical-grade WHOOP MG, founder and CEO Will Ahmed is ushering in a new era for wearable technology — one that goes far beyond fitness tracking. In this interview with Gulf Business, the health tech pioneer shares how the latest innovations position the brand as a central operating system for human health. From AI-powered insights that drive meaningful behaviour change to the platform's growing popularity in the Middle East, Ahmed outlines how WHOOP is redefining performance, longevity, and recovery for its global user base. What makes the WHOOP 5.0 launch a true leap forward for the brand — rather than just the next iteration? This launch marks the beginning of a new chapter for us. With the launch of WHOOP 5.0 and WHOOP MG, along with our new health software features, WHOOP 5.0 and WHOOP MG introduce medical-grade capabilities and insights never before offered in a single wearable. The new sensors deliver 14 days of battery life — three times what our last device offered — while being 7 per cent smaller. WHOOP MG builds on that with Heart Screener with ECG, Irregular Heart Rhythm Notifications, and Blood Pressure Insights. We've also introduced new software features including Healthspan with WHOOP Age, updated Sleep Performance, Hormonal Insights, and an improved Steps experience — all designed to help members perform better and live longer. This isn't just a product update. It's the biggest leap forward in WHOOP technology to date, not just to our hardware, but to the entire WHOOP experience. As wearables grow in popularity, how is WHOOP helping users turn data into meaningful behavior change and long-term habits? WHOOP is transforming how people turn data into meaningful behavior change and lasting habits by shifting the focus from passive data collection to personalised, actionable insights that drive outcomes. WHOOP does this through a deeply integrated system of features designed to coach rather than just track. For instance, our new Healthspan with WHOOP Age reveals how your behaviours — from sleep to strength training — are directly influencing your physiological age. This isn't just data — it becomes a call to action to our members. How would you describe the significance of the Middle East market for WHOOP — and what sets this region apart in terms of demand and adoption? The GCC is a rapidly growing This is a region that deeply values performance, health, and innovation. What's unique here is the demand for premium, personalised solutions — and WHOOP is uniquely equipped to meet that. Looking ahead, as wearables evolve beyond fitness to support long-term wellbeing and healthspan, where is WHOOP heading next ? In the coming months and year, we will be focused on additional new features that help support our goal of becoming a central operating system for our members' health. One of those initiatives is WHOOP Advanced Labs — our soon-to-be-released feature that integrates blood testing right into your WHOOP experience to provide an enhanced layer of coaching. Any recovery tips you can share with users based on your experience? There are many tools and strategies I use to optimise my recovery, including wearing blue light glasses before bed and cold plunging after working out. I also find meditation personally has been one of the biggest unlocks for me. I do it every morning for 20 minutes and it's become nonnegotiable for me. When I was 24 years old I was really stressed about building WHOOP. I was run down, strung out, and I hadn't really learned how to cope with stress. I found meditation as a tool to really find balance and reflection. It allowed me to develop this ability to look at my thoughts in the third person. It made me feel much more in control and aware.
Zawya
13 hours ago
- Zawya
BEEAH expands into real estate development
BEEAH, the region's sustainability and innovation pioneer, has formally announced its strategic expansion into real estate development. The move builds on the organisation's experience managing real estate developments, including the established strengths in Environment, Energy, Technology, and Healthcare, reinforcing its commitment to shaping future-ready cities and enhancing quality of life for societies. The expansion reflects BEEAH's deliberate diversification strategy that integrates sustainability at its core, while fostering the organisation's growth in emerging, high-impact industries. 'Developing real estate is a natural evolution for BEEAH, unlocking a new avenue for us to address society's most pressing challenges. Our goal is to create exceptional urban environments, setting new regional benchmarks and creating a world-class model for elevated living in tomorrow's cities,' said Khaled Al Huraimel, Group CEO and Vice Chairman of BEEAH. 'Our real estate projects are incorporating principles of sustainability, innovation, and commitment to quality of life from the ground up, while building on our accomplishments to date in the Environment, Technology, Energy, and Healthcare sectors.' With over a decade of multi-faceted experience developing projects, BEEAH is uniquely positioned in the real estate industry, from building the iconic BEEAH Headquarters designed by the world-renowned Zaha Hadid Architects and building sustainable, industrial projects, to its latest work on the upcoming Jawaher Boston Medical District designed by Renzo Piano Building Workshop (RPBW). Earlier this year, BEEAH was also appointed as project manager and strategic lead of the upcoming Sharjah Creative Quarter project, designed by award-winning architectural firm Taller de Arquitectura – Mauricio Rocha in collaboration with Daniel Rosselló. In the weeks ahead, BEEAH will unveil a landmark development set to redefine the future of real estate in the region with smart sustainable design and a new standard for modern urban living. In the Environment sector, BEEAH continues to lead the region in waste-to-value solutions and pursue total landfill diversion. Building on its pioneering waste collection services that have set benchmarks for operational excellence and integrated recycling innovations with AI and robotics, BEEAH has developed an end-to-end waste management ecosystem that has contributed to achieving one of the world's highest landfill diversion rates in the Emirate of Sharjah – over 90%. The organisation's excellence in waste management has also fuelled its expansion to Egypt and the Kingdom of Saudi Arabia, where they are helping shape cleaner and more circular cities. Going beyond its own operations in the region, BEEAH continues to launch educational initiatives and awards to engage student communities and societies to be environmentally responsible. For industries, BEEAH is also advancing environmental consulting services to tackle the challenges of waste and emissions. As part of the Energy sector, BEEAH is at the forefront of waste-to-energy, hydrogen-from-waste, and solar technologies. Its Sharjah Waste-to-Energy plant, inaugurated in 2022, transforms hard-to-recycle waste into clean energy and is currently expanding to double its capacity. Its upcoming Hydrogen-from-Waste project has demonstrated breakthroughs for hydrogen production during initial trials in Nottingham, UK. BEEAH is also advancing solar projects in line with net-zero strategies. In the Technology sector, BEEAH is driving digital transformation through several key ventures. its digital ecosystem venture, has developed platforms that are disrupting the recycling, logistics, and moving industries. Its digital venture EVOTEQ is also transforming supply chain integrity through its 'traq' platform. Within green mobility, BEEAH's ION joint venture with Crescent Enterprises is transforming EV charging by connecting charger owners and users through a singular platform. BEEAH is also building Sharjah's first Tier III data center around groundbreaking principles of sustainability through its Khazna Sharjah partnership. Within the Healthcare sector, BEEAH's efforts reflect a deepening commitment to enhancing quality of life for all societies. Its upcoming Jawaher Boston Medical District (JBMD) project is a hospital of the future built in strategic partnership with renowned medical institutions from Boston, United States. The patient-centric campus will combine state-of-the-art treatments with sustainable design and serene green spaces to promote holistic wellbeing. Complementing the project is Wekaya, a BEEAH venture that delivers innovative circular solutions for medical waste, and 'traqpharma', a technology built on EVOTEQ's 'traq' platform, which is enhancing pharmaceutical supply chain integrity across the UAE. BEEAH's expansion into real estate development alongside its core sectors marks a defining milestone, positioning the organisation as a comprehensive innovation pioneer aligned with national efforts towards a smart, sustainable, and diversified economy.
